Share this Post

Corvia Medical, Inc. is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices.

The company has developed the world’s first transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). The InterAtrial Shunt Device (IASD®) is designed to relieve elevated left atrial pressure (LAp), the main cause of heart failure symptoms. The IASD System is designed to be cost-effective and is intended to dramatically improve patients’ quality of life, while significantly reducing hospitalization costs.